The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease
Abstract
HMGB1 is a non-histone nuclear protein that can serve as an alarmin to drive the pathogenesis of inflammatory and autoimmune disease. Although primarily located in the cell nucleus, HMGB1 can translocate to the cytoplasm, as well as the extracellular space, during cell activation and cell death; during activation, HMGB1 can undergo post-translational modifications. The activity of HMGB1 varies with the redox states of the cysteine residues, which are required for binding to TLR4. In addition to stimulating cells directly, HMGB1 can form immunostimulatory complexes with cytokines and other endogenous and exogenous factors. In the synovia of patients with rheumatoid arthritis, as well as animal models of this disease, extranuclear expression of HMGB1 is increased and blockade of HMGB1 expression attenuates disease in animal models. In systemic lupus erythematosus, HMGB1 can be a component of immune complexes containing anti-DNA because of its interaction with DNA. In myositis, expression of HMGB1 is enhanced in inflamed muscle and can perturb muscle function. Together, these findings indicate that HMGB1 might be an important mediator and biomarker in rheumatic diseases as well as a target of new therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, the expression of HMGB1, an alarmin that conveys injury signals to surrounding cells, was higher in the AD-up-regulated subpopulations than the AD-down-regulated subpopulation (SI Appendix, Fig. S5D) (20).”
From Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer’s disease (2020) · cites this paper as [20]
In the citing paper
“TFAM is a DNA-binding protein belonging to the same family as high mobility group box 1 protein and is a very important alarmin involved in inflammation and autoimmune disorders209.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [209]
Citations
Cites
3 retracted
Yang, H., Lundbäck, P., Ottosson, L., Erlandsson-Harris, H., Venereau, E., Bianchi, M. E., Al-Abed, Y., Andersson, U., Tracey, K. J., & Antoine, D. J. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00389 · Cited by 407
Self-citationRetractedAntoine, D. J., Williams, D. P., Kipar, A., Laverty, H., & Park, B. K. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00126 · Cited by 102
RetractedTaira, T., Matsuyama, W., Mitsuyama, H., Kawahara, K.-I., Higashimoto, I., Maruyama, I., Osame, M., & Arimura, K. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03347.x · Cited by 20
RetractedRelease of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Self-citationImmunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787
Park, J. S., Svetkauskaite, D., He, Q., Kim, J., Strassheim, D., Ishizaka, A., & Abraham, E. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306793200 · Cited by 1,582
HMGB1 is a therapeutic target for sterile inflammation and infection
Andersson, U., & Tracey, K. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101323 · Cited by 1,437
Self-citationAndersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
Self-citationTian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
Cited by
Sorted by citations
Items 601–692 of 692
Fujiki, T., Nishimura, R., Sato, K., Kuroda, R., Wang, X., Matsushita, T., Mase, S., Araki, R., Ikawa, Y., Maeba, H., et al. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf169 · Cited by 1
Mao, Y., Patial, S., & Saini, Y. (2026) · Scientific Reports · doi:10.1038/s41598-025-33357-0 · Cited by 1
Tackling Sepsis Using Host Defense Peptides That Reduce Proinflammatory Cytokine Production
Wedamulla, P. G., & Straus, S. K. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c01040 · Cited by 1
Liu, D., Zhang, S., Xia, F., Shi, Q., Zhao, H., Wong, Y., Meng, Y., Liu, Y., Zhu, Y., Chai, X., et al. (2026) · Acupuncture and Herbal Medicine · doi:10.1097/hm9.0000000000000181 · Cited by 1
High mobility group box 1: DAMPening the danger molecule in cardiovascular disease with exercise
Liao, Y.-C., & Goh, J. (2026) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2026.100161 · Cited by 1
Non-Hyperuricemia Experimental Models of Gout
Xiang, Y., Chien, A.-T., & Hall, C. J. (2026) · Gout Urate and Crystal Deposition Disease · doi:10.3390/gucdd4010008 · Cited by 1
Alghubayshi, A., Almuntashiri, S., Atia, H. A., Emam, M. N., & Kabel, A. M. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116662 · Cited by 1
Pharmacological intervention of the HMGB1-pCTS-L axis to ameliorate inflammatory diseases
Chen, W., Li, J., Qiang, X., Li, L., Zhu, S., Deng, M., & Wang, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1843251 · Cited by 1
Paz-Villatoro, J. M., Yu, B., Songe, O., Wang, X., & Iwahara, J. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2538042123 · Cited by 2
Circulating omentin-1 and HMGB1 levels in patients with Hashimoto thyroiditis
Genç, S., Mercantepe, F., Aksu, O., Can, Ü., Kızılarslanoğlu, M. C., & Klisic, A. N. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.121195 · Cited by 1
Immunopathogenesis of Bacterial Meningitis
Koedel, U., Klein, M., & Pfister, H. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1071-7_18 · Cited by 1
Yu, X., Xia, Q., & Le, K. (2022) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-022-00305-2 · Cited by 1
Genetic Expression of High Mobility Group Box 1 in Neonatal Sepsis
Haie, O. M. A., Elbeshery, M. A., Husein, S., & Abed, N. T. (2022) · Benha Medical Journal · doi:10.21608/bmfj.2022.172219.1702 · Cited by 1
Baek, J., & Kim, S. (2023) · Transplantation Proceedings · doi:10.1016/j.transproceed.2023.02.053 · Cited by 1
Wei, X., Chen, Y., Long, F., Yu, S., Xu, S., & Chen, X. (2023) · International Journal of Dermatology and Venereology · doi:10.1097/jd9.0000000000000320 · Cited by 1
Sawada, K., Shimomura, Y., Hasegawa, D., Harada, T., Nakamura, T., Kuriyama, N., Hara, Y., Komura, H., & Nishida, O. (2023) · PubMed Central · doi:10.20407/fmj.2022-008 · Cited by 1
Yıldırım, D., Alp, G. T., Kilicarslan, H., Vasi, I., & Küçük, H. (2024) · Journal of Clinical and Experimental Investigations · doi:10.29333/jcei/14364 · Cited by 1
Prognostic value of serum high-mobility group box 1 in neonates with neonatal encephalopathy
Jiang, R., & Yang, X. (2024) · Pediatric Research · doi:10.1038/s41390-024-03408-9 · Cited by 1
Navaseelan, L., Retinasamy, T., Shaikh, M. F., & Arulsamy, A. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2909322 · Cited by 1
Route to Discovering the Immunogenic Properties of DNA from TLR9 to Cytosolic DNA Sensors
Tang, C. K., Coban, C., Akira, S., & Ishii, K. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-404732-7.00001-0 · Cited by 1
Zhang, B., Wang, H., Wang, Y., Yang, M., Gu, J., & Yao, M. (2018) · Europe PMC (PubMed Central) · Cited by 1
Xu, Y., Ye, C., Tang, L., Pan, B., & Li, Y. (2020) · PubMed · doi:10.11817/j.issn.1672-7347.2020.190150 · Cited by 1
Amiri, S., Rabbani‐Chadegani, A., Davoodi, J., & Fakhrabadi, H. G. (2021) · PubMed Central · doi:10.22074/cellj.2021.7332 · Cited by 1
Zickert, A. (2013) · Figshare · Cited by 1
Etiopathogenesis of systemic autoimmune diseases
Kallenberg, C. G. M. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32835cf2d1 · Cited by 1
The chromatin architectural protein DEK : assessing its chromatin binding properties
Guo, H., Lüscher, B., & Kappes, F. (2016) · RWTH Publications (RWTH Aachen) · Cited by 1
Lawlor, K. E., Conos, S. A., & Vince, J. E. (2018) · Wiley eBooks · doi:10.1002/9781119432463.ch15 · Cited by 1
Immune-Mediated Mechanisms of Atherosclerosis
Bäck, M., Ketelhuth, D. F. J., Malin, S., Olofsson, P. S., Paulsson‐Berne, G., Yan, Z.-Q., & Hansson, G. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99556-5 · Cited by 1
Zheng, Q., & Dai, Z. (2025) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2025-0070ed · Cited by 1
Mechanisms of Astrocyte Contribution to Bortezomib-Induced Peripheral Neuropathy
Robinson, C. R. (2014) · Digital Commons-TMC (Texas Medical Center)
Clinical and molecular studies in ANCA associated vasculitis
Wendt, M. (2014) · Figshare
Cell Death and Anti-DNA Antibodies
Hirabayashi, Y. (2012) · InTech eBooks · doi:10.5772/48343
Microglia demostrate age-dependent performance and interaction with beta-amyloid peptide
Lidónio, G. M. D. C., Brites, D. M. T. O., & Dias, D. M. A. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Molecular mechanisms in idiopathic inflammatory myopathies
Zong, M. (2014) · Open Archive (Karolinska Institutet)
Autophagy, Cell Death, and Cancer
Mehrpour, M., Hamaï, A., & Codogno, P. (2013) · Springer eBooks · doi:10.1007/978-94-007-6211-4_14
New available biomarkers to face a worldwide emergency: The childhood obesity
Chirico, V., Lacquaniti, A., Manti, S., Cuppari, C., D’Angelo, G., Lanzafame, A., Filippelli, M., Munafò, C., Salpietro, C. D., & Arrigo, T. (2016) · Journal of Pediatric Biochemistry · doi:10.3233/jpb-140118
High-mobility group box 1 protein may be a therapeutic target in inflammation
Yen, M. (2013) · Acta anaesthesiologica Taiwanica · doi:10.1016/j.aat.2013.03.008
EXPRESSÃO GÊNICA DE TLR-2, TLR-4, HMGB1 E VEGF EM ÚLCERAS ABOMASAIS EM BOVINOS DE CORTE
Bentin, L. A. T. (2017) · Americanae (AECID Library)
Schindler, S. M. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0074420
High mobility group box-1 (hmgb1) in systemic vasculitides
de Souza, A. S. (2015)
The Role of Microparticles as Biomarkers in the Development of Therapy for Autoimmune Disease
Pisetsky, D. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-42252-7_3
Self-citationOBSOLETE: Immune-mediated Mechanisms of Atheroslcerosis
Bäck, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99556-4
AB0129 HMGB1+ microparticles in systemic lupus erythematosus patients with lupus nephritis
Burbano, C., Gόmez-Puerta, J., Rojas, M., Vásquez, G. M., Orejuela-Erazo, J., Muñoz, C., Vanegas-García, A. L., & Castaño, D. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-eular.4397
The Effects of Mechanical Ventilation on Neutrophil Extracellular Trap Formation
Yildiz, C. (2013) · TSpace (University of Toronto)
Developing cancer immunotherapy by activating macrophage tumoricidal activity
Avdagic, A. (2017) · NORA - Norwegian Open Research Archives
HMGB1 INDUCES TENDINOPATHY DEVELOPMENT DUE TO MECHANICAL OVERLOADING
Zhang, J., Zhao, G., Li, F., & Hc, J. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
HMGB1 orchestrates uterine macrophage trafficking to safeguard embryo implantationPreprint
Aikawa, S., Deng, W., Liang, X., Yuan, J., Bartos, A., Sun, X., & Dey, S. K. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/522490
Ghosh, S., Bhattacharya, M., Kar, A., Das, B. K., & Patra, B. C. (2019) · ExRNA · doi:10.1186/s41544-019-0010-4
Su, Z., Ni, P., She, P., Liu, Y., Richard, S. A., Xu, W., Zhu, H., & Wang, J. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02489-9
Retractedガングリオシドのアシル鎖構造によるToll-like receptor 4活性化制御メカニズム
裕考, 狩., 昂大, 新., 藤居真優, 樺山一哉, 敦史, 下., 浩一, 深., Sonnino, S., 明身, 鈴., & 仁一, 井. (2019) · doi:10.24753/jeiis.22.0_1
Fu, D., Lou, H.-Y., Hu, R., Kong, C., Chen, Y.-R., Wang, L. L., Chen, B., & Dai, A. (2021) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2021.101990
RetractedHMGB1 and IL-33 kinetics in trauma and hemorrhagic shock: A prospective study in trauma patients
Ottestad, W. (2020) · NORA - Norwegian Open Research Archives
Li, Y., Xu, W., Ren, Y., Cheung, H., Huang, P., Kaur, G., Kuo, C., McDonough, S. P., Fubini, S. L., Lipkin, S. M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.02.450318
민현진 (2013) · YUHSpace (Yonsei University Medical Library)
Characterization of Multiple Surface Loops in Escherichia coli Biotin Protein Ligase Functions
Adikaram, P. R. (2012) · University Libraries (University of Maryland)
Ejes inflamatorios y alarminas en el intestino delgado en enfermedad celíaca
Pérez, F. (2021) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/129881
Protein Moonlighting and Human Health and Idiopathic Human Disease
Henderson, B. E., Fares, M. A., & Martin, A. C. R. (2016) · Wiley eBooks · doi:10.1002/9781118952108.ch7
Kanoh, H. (2022) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.21-00193
Chen, X., Zheng, X., Shen, T., He, T., Zhao, Y., & Dong, Y. (2023) · Acta Histochemica · doi:10.1016/j.acthis.2023.152111
Liu, D., Luo, P., Gu, L., Zhang, Q., Gao, P., Zhu, Y., Chen, X., Guo, Q., Zhang, J., Ma, N., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15139430
Orujova, P. A., & Sultanova, N. (2024) · World of Medicine and Biology · doi:10.26724/2079-8334-2024-2-88-104-108
Caracci, B., Pehora, C., Benson, L. N., Steinberg, B. E., Goldenberg, N. M., & Taylor, K. L. (2024) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2024.07.020
Myeloid cell-specific HMGB1 deficiency exaggerates mucoinflammatory response in Scnn1b-Tg+ micePreprint
Mao, Y., Patial, S., & Saini, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-5510137/v1
Heestermans, M., Arthaud, C., Prier, A., Eyraud, M., Hamzeh‐Cognasse, H., Cognasse, F., & Duchez, A. (2025) · Vox Sanguinis · doi:10.1111/vox.70033
Liu, D., Zhang, S., Shi, Q., Xia, F., Zhao, H., Wong, Y., Meng, Y., Liu, Y., Zhu, Y., Chai, X., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5226089
Aβ-HMGB1 complex is a pathogenic molecule at the advanced stage of Alzheimer’s diseasePreprint
Tanaka, H., Homma, H., Yoshioka, Y., Fujita, K., Yamada, S., Furukawa, K., Ishiki, A., Atsuta, N., Waragai, M., Mano, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.12.659430
Osuna‐Gómez, R., Castellvi, I., Mulet, M., Tandaipan, J. L., Zamora, C., Codes-Méndez, H., Ortiz, M. A., Díaz‐Torné, C., Cantó, E., Magallares, B., et al. (2025) · Translational research · doi:10.1016/j.trsl.2025.07.001
Uluç, F., Türkoğlu, Ş. A., Çelik, B. G., Karabörk, Ş., & Kayış, S. A. (2025) · Neurological Research · doi:10.1080/01616412.2025.2551093
Assessment of circulatory levels of high mobility group box 1 in patients with nonsegmental vitiligo
Taher, F., Elmazny, G. M., Alghobary, M. F., & Ali, M. (2025) · Egyptian Journal of Dermatology and Venerology · doi:10.4103/ejdv.ejdv_65_24
The roles and diversity of alarmins in the mucosae
Gaultney, R. A., Herbst, A., Yeoh, J., Bessell, E., & Krebs, P. (2025) · Advances in immunology · doi:10.1016/bs.ai.2025.09.001
Platform for drug discovery targeting HMGB1, AGEs-RAGE response
Mori, S., Takahashi, H. K., & Toyomura, T. (2014) · Folia Pharmacologica Japonica · doi:10.1254/fpj.143.14
zhang, Q., Chen, Y., Wang, Q., Wang, Y., Feng, W., Chai, L., Liu, J., Li, D., Chen, H., Qiu, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26593580
Meng, X., Na, R., Peng, X., Li, H., Ouyang, W., Zhou, W., You, X., Li, Y., Pu, X., Zhang, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26679977
Meng, X., Na, R., Peng, X., Li, H., Ouyang, W., Zhou, W., You, X., Li, Y., Pu, X., Zhang, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25210502
Wang, M., Gauthier, A. G., Kennedy, T. P., Wang, H., Velagapudi, U. K., Talele, T. T., Lin, M., Wu, J., Daley, L., Yang, X., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14998770
Meng, X., Na, R., Peng, X., Li, H., Ouyang, W., Zhou, W., You, X., Li, Y., Pu, X., Zhang, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26679974
Meng, X., Na, R., Peng, X., Li, H., Ouyang, W., Zhou, W., You, X., Li, Y., Pu, X., Zhang, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25210846
Lin, M., Long, J., Li, W., Yang, C., Loughran, P., O’Doherty, R., Billiar, T. R., Deng, M., & Scott, M. J. (2020) · Figshare · doi:10.6084/m9.figshare.13290491
Wen, X., Rosmark, J., Versteegen, A., Sunderberg, E., Altman, M., Aulin, C., & Harris, H. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.13.711592
Self-citationCrizotinib-Induced Immunogenic Cell Death in Non-Small Cell Lung Cancer
Liu, P. (2018) · theses.fr (ABES) · doi:10.70675/ed550df1z9febz41d6z9846z294a6695b865
Millerand, M. (2020) · theses.fr (ABES) · doi:10.70675/d5e9dae6zd9d7z4a05z8fd2zf0ff4ffab0a6
Inhibition of HMGB1/TLR4 signaling pathway by Schisandrin in RAW264.7 murine macrophages
Jung, D. E., Lee, Y. S., Seo, J. W., Park, J. S., Na, H. J., Hong, J. W., Kim, S.-H., & Shin, J. (2026) · Food Science and Biotechnology · doi:10.1007/s10068-026-02148-2
Li, B., Zhu, E., Wang, Y., Hu, Y., Zhang, Q., & Li, F. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153869
Detection of Calpain-Mediated Beclin-1 Cleavage for Drug Discovery in Inflammatory Bowel Diseases
Hunter, K. A., Overstreet, A.-M. C., Koff, B. B., Dharan, H., Overend, S. H., & Messer, J. S. (2026) · Cells · doi:10.3390/cells15100917
Kumar, A., Mahajan, A., Krishnamachary, B., Chen, L., & Dhillon, N. K. (2026) · Comprehensive physiology · doi:10.1002/cph4.70191
Aptamer targeting HMGB1 attenuates inflammatory disease via domain-specific antagonism
Zhang, H., Ma, L., Gan, S., Jiang, M., Zhang, Z., Sun, W., Xie, W., Xi, P., Qu, F., & Tan, W. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.06.011
BindingDB (2026) · UC San Diego · doi:10.7270/q2th8sjz
Li, D., Yang, G., Yu, Y., Chen, S. L., Wang, R., Lv, C., Ma, S., 王世鑫, 徐希明, Xia, X., et al. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119474
Metadata
- Authors
- Harris, H. E., Andersson, U., & Pisetsky, D. S.
- Affiliations
- Karolinska Institutet (SE)
- Karolinska University Hospital (SE)
- Durham VA Medical Center (US)
- Corresponding author
- Pisetsky, David S.
- Venue
- Nature Reviews Rheumatology
- Published
- 2012-01-31
- Volume
- 8
- Issue
- 4
- Pages
- 195-202
- ISSN
- 1759-4790 (ISSN-L)
- 1759-4804
- OpenAlex
- W1972204333
- Cited by
- 689
- References
- 93
- Citations by year
- 2026: 20 · 2025: 31 · 2024: 32 · 2023: 34 · 2022: 54 · 2021: 61 · 2020: 50 · 2019: 59 · 2018: 65 · 2017: 57 · 2016: 53 · 2015: 52 · 2014: 55 · 2013: 49 · 2012: 16
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Rheumatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- Reumatikerförbundet
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (AI-056363, U19AI056363)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Keywords
- HMGB1, alarmins, non-histone nuclear proteins, rheumatoid arthritis, systemic lupus erythematosus, myositis, inflammation, autoimmune disease, TLR4, post-translational modification, cysteine redox state, extracellular HMGB1, immune complexes, anti-DNA antibodies, synovium, biomarkers, therapeutic target
- MeSH terms
- Animals, Autoimmune Diseases, DNA-Binding Proteins, Humans, Inflammation, Rheumatic Diseases, Signal Transduction, HMGB1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review